Novel candidate genes of thyroid tumourigenesis identified in Trk-T1 transgenic mice

Endocrine-Related Cancer

Volumn 19, Issue 3, 2012, Pages 409-421

  Heiliger, Katrin Janine ^a   Hess, Julia ^a   Vitagliano, Donata ^b   Salerno, Paolo ^b   Braselmann, Herbert ^a   Salvatore, Giuliana ^c   Ugolini, Clara ^d   Summerer, Isolde ^a   Bogdanova, Tatjana ^e   Unger, Kristian ^f   Thomas, Gerry ^f   Santoro, Massimo ^b   Zitzelsberger, Horst ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^d UNIVERSITY OF PISA   (Italy)

^e STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BMPR 1B GENE; CARCINOGENESIS; CHILD; CHROMOSOME BAND; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; MALE; MOUSE; NONHUMAN; PDE 6D GENE; PDLIM 5 GENE; PTMA GENE; SCHOOL CHILD; SLITRK 5 GENE; SRM GENE; TAF 12 GENE; THYROID CANCER; THYROID PAPILLARY CARCINOMA; TRANSGENIC MOUSE; TRP 73 GENE; TUMOR GENE; TWIST 2 GENE; UNC 5C GENE; UPREGULATION; YTHDF 2 GENE;

ADOLESCENT; ADULT; ANIMALS; CHILD; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; RECEPTOR, TRKA; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84862649335     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-11-0387     Document Type: Article

References (38)

1. Ansieau S, Bastid J, Doreau A, Morel AP, Bouchet BP, Thomas C, Fauvet F, Puisieux I, Doglioni C, Piccinin S et al. 2008 Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14 79-89. (doi:10.1016/j.ccr.2008.06.005)
2. Aruga J & Mikoshiba K 2003 Identification and characterization of Slitrk, a novel neuronal transmembrane protein family controlling neurite outgrowth. Molecular and Cellular Neurosciences 24 117-129. (doi:10.1016/S1044- 7431(03)00129-5)
3. Aruga J, Yokota N & Mikoshiba K 2003 Human SLITRK family genes: genomic organization and expression profiling in normal brain and brain tumor tissue. Gene 315 87-94. (doi:10.1016/S0378-1119(03)00715-7)
4. Birnboim HC & Doly J 1979 A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Research 7 1513-1523. (doi:10.1093/nar/7.6.1513)
5. Bongarzone I, Pierotti MA, Monzini N, Mondellini P, Manenti G, Donghi R, Pilotti S, Grieco M, Santoro M, Fusco A et al. 1989 High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 4 1457-1462. (Pubitemid 20008924)
6. Chung YJ, Jonkers J, Kitson H, Fiegler H, Humphray S, Scott C, Hunt S, Yu Y, Nishijima I, Velds A et al. 2004 A whole-genome mouse BAC microarray with 1-Mb resolution for analysis of DNA copy number changes by array comparative genomic hybridization. Genome Research 14 188-196. (doi:10.1101/gr.1878804)
7. Greco A, Miranda C & Pierotti MA 2010 Rearrangements of NTRK1 gene in papillary thyroid carcinoma. Molecular and Cellular Endocrinology 321 44-49. (doi:10.1016/j.mce.2009.10.009)
8. Hanzal-Bayer M, Renault L, Roversi P, Wittinghofer A &Hillig RC 2002 The complex of Arl2-GTP and PDE delta: from structure to function. EMBO Journal 21 2095-2106. (doi:10.1093/emboj/21.9.2095)
9. Hedinger C, Williams ED & Sobin LH 1989 The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 63 908-911. (doi:10.1002/1097-0142(19890301)63:5〈908::AID- CNCR2820630520〉3.0.CO;2-I)
10. Hess J, Thomas G, Braselmann H, Bauer V, Bogdanova T, Wienberg J, Zitzelsberger H & Unger K 2011 Gain of chromosome band 7q11 in papillary thyroid carcinomas of young patients is associated with exposure to low-dose irradiation. PNAS 108 9595-9600. (doi:10.1073/pnas.1017137108)
11. Hupe P, Stransky N, Thiery JP, Radvanyi F & Barillot E 2004 Analysis of array CGH data: from signal ratio to gain and loss of DNA regions. Bioinformatics 20 3413-3422. (doi:10.1093/bioinformatics/bth418)
12. Jarvinen AK, Autio R, Kilpinen S, Saarela M, Leivo I, Grenman R, Makitie AA & Monni O 2008 High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx. Genes, Chromosomes &Cancer 47 500-509. (doi:10.1002/gcc.20551)
13. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, Xing S & Ledent C 1996 Targeted expression of the ret/PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137 375-378. (doi:10.1210/en.137.1. 375)
14. Jokinen MP & Botts S 1994 Tumours of the thyroid gland. IARC Scientific Publications 111 565-594.
15. Karetsou Z, Martic G, Tavoulari S, Christoforidis S, Wilm M, Gruss C & Papamarcaki T 2004 Prothymosin alpha associates with the oncoprotein SET and is involved in chromatin decondensation. FEBS Letters 577 496-500. (doi:10.1016/j.febslet.2004.09.091)
16. Kim CS & Zhu X 2009 Lessons from mouse models of thyroid cancer. Thyroid 19 1317-1331. (doi:10.1089/thy.2009.1609)
17. Knauf JA & Fagin JA 2009 Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets. Current Opinion in Cell Biology 21 296-303. (doi:10.1016/j.ceb.2009.01.013)
18. La Rosa P, Viara E, Hupe P, Pierron G, Liva S, Neuvial P, Brito I, Lair S, Servant N, Robine N et al. 2006 VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles. Bioinformatics 22 2066-2073. (doi:10.1093/bioinformatics/btl359)
19. Leys CM, Nomura S, LaFleur BJ, Ferrone S, Kaminishi M, Montgomery E & Goldenring JR 2007 Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer. Surgery 141 41-50. (doi:10.1016/j.surg.2006. 05.009)
20. Liva S, Hupe P, Neuvial P, Brito I, Viara E, La Rosa P &Barillot E 2006 CAPweb: a bioinformatics CGH array analysis platform. Nucleic Acids Research 34 W477-W481. (doi:10.1093/nar/gkl215)
21. Livak KJ & Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 402-408. (doi:10.1006/meth.2001.1262)
22. Milde T, Shmelkov SV, Jensen KK, Zlotchenko G, Petit I &Rafii S 2007 A novel family of slitrk genes is expressed on hematopoietic stem cells and leukemias. Leukemia 21 824-827. (doi:10.1038/sj.leu.2404525)
23. Nancy V, Callebaut I, El Marjou A & de Gunzburg J 2002 The delta subunit of retinal rod cGMP phosphodiesterase regulates the membrane association of Ras and Rap GTPases. Journal of Biological Chemistry 277 15076-15084. (doi: 10.1074/jbc.M109983200)
24. Neuvial P, Hupe P, Brito I, Liva S, Manie E, Brennetot C, Radvanyi F, Aurias A & Barillot E 2006 Spatial normalization of array-CGH data. BMC Bioinformatics 7 264. (doi:10.1186/1471-2105-7-264)
25. Nikiforov YE 2008 Thyroid carcinoma: molecular pathways and therapeutic targets. Modern Pathology 21 (Suppl 2) S37-S43. (doi:10.1038/modpathol.2008.10)
26. Ojima E, Inoue Y, Miki C, Mori M & Kusunoki M 2007 Effectiveness of gene expression profiling for response prediction of rectal cancer to preoperative radiotherapy. Journal of Gastroenterology 42 730-736. (doi:10.1007/s00535-007-2089-x)
27. Osoegawa K, Tateno M, Woon PY, Frengen E, Mammoser AG, Catanese JJ, Hayashizaki Y & de Jong PJ 2000 Bacterial artificial chromosome libraries for mouse sequencing and functional analysis. Genome Research 10 116-128. (doi:10.1101/gr.10.1.116)
28. Osoegawa K, Mammoser AG, Wu C, Frengen E, Zeng C, Catanese JJ & de Jong PJ 2001 A bacterial artificial chromosome library for sequencing the complete human genome. Genome Research 11 483-496. (doi:10.1101/gr.169601)
29. Powell DJ Jr, Russell J, Nibu K, Li G, Rhee E, Liao M, Goldstein M, Keane WM, Santoro M, Fusco A et al. 1998 The RET/PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Research 58 5523-5528. (Pubitemid 28551140)
30. Powell N, Jeremiah S, Morishita M, Dudley E, Bethel J, Bogdanova T, Tronko M & Thomas G 2005 Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation exposure. Journal of Pathology 205 558-564. (doi:10.1002/path.1736)
31. Richter H, Slezak P, Walch A, Werner M, Braselmann H, Jaramillo E, Ost A, Hirata I, Takahama K & Zitzelsberger H 2003 Distinct chromosomal imbalances in nonpolypoid and polypoid colorectal adenomas indicate different genetic pathways in the development of colorectal neoplasms. American Journal of Pathology 163 287-294. (doi:10.1016/S0002-9440(10)63652-8)
32. Rouveirol C, Stransky N, Hupe P, Rosa PL, Viara E, Barillot E & Radvanyi F 2006 Computation of recurrent minimal genomic alterations from array-CGH data. Bioinformatics 22 849-856. (doi:10.1093/bioinformatics/btl004)
33. Russell JP, Powell DJ, Cunnane M, Greco A, Portella G, Santoro M, Fusco A & Rothstein JL 2000 The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. Oncogene 19 5729-5735. (doi:10.1038/sj.onc.1203922)
34. Salerno P, Garcia-Rostan G, Piccinin S, Bencivenga TC, Di Maro G, Doglioni C, Basolo F, Maestro R, Fusco A, Santoro M et al. 2011 TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype. Journal of Clinical Endocrinology and Metabolism 96 E772-E781. (doi:10.1210/jc.2010- 1182)
35. Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G et al. 1996 Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 12 1821-1826. (Pubitemid 26146307)
36. Unger K, Zitzelsberger H, Salvatore G, Santoro M, Bogdanova T, Braselmann H, Kastner P, Zurnadzhy L, Tronko N, Hutzler P et al. 2004 Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism 89 4272-4279. (doi:10.1210/jc.2003-031870)
37. Unger K, Malisch E, Thomas G, Braselmann H, Walch A, Jackl G, Lewis P, Lengfelder E, Bogdanova T, Wienberg J et al. 2008 Array CGH demonstrates characteristic aberration signatures in human papillary thyroid carcinomas governed by RET/PTC. Oncogene 27 4592-4602. (doi:10.1038/onc.2008.99)
38. Zheng Q & Wang XJ 2008 GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis. Nucleic Acids Research 36 W358-W363. (doi:10.1093/nar/gkn276)